Age impacts pharmacogenomics and treatment outcomes for the most common form of leukemia (IMAGE)
Caption
Jun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura, MD, PhD, demonstrated that treatment and age impact outcomes for B-cell acute lymphoblastic leukemia.
Credit
Courtesy of St. Jude Children's Research Hospital
Usage Restrictions
none
License
Original content